Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 15-Feb-24 9:14 PM View:  | Denali Therapeutics Inc. (DNLI) | 14-Feb-24 | Sale (Planned) | 1,405 | $17.79 | $24,995.00 | (< 1%) 353.23K to 351.82K | |
| 15-Feb-24 9:14 PM View: | Denali Therapeutics Inc. (DNLI) | 13-Feb-24 | Sale | 2,784 | $17.29 | $48,135.40 | (< 1%) 356.01K to 353.23K | |
| 12-Jan-24 8:18 PM View: | Denali Therapeutics Inc. (DNLI) | 10-Jan-24 | Sale (Planned) | 4,668 | $19.02 | $88,785.40 | (1%) 360.68K to 356.01K | |
| 09-Jan-24 7:35 PM View: | Denali Therapeutics Inc. (DNLI) | 05-Jan-24 | Sale Duplicate | 9,972 | $19.43 | $193,756.00 | (3%) 370.65K to 360.68K | |
| 05-Jan-24 5:57 PM View: | Denali Therapeutics Inc. (DNLI) | 03-Jan-24 | Grant | 53,720 | -- | -- | 17% 316.93K to 370.65K | |
| 25-Aug-23 5:30 PM View: | Denali Therapeutics Inc. (DNLI) | 23-Aug-23 | Sale (Planned) | 2,522 | $23.22 | $58,560.80 | (< 1%) 319.45K to 316.93K | |
| 23-Aug-23 4:34 PM View: | Denali Therapeutics Inc. (DNLI) | 21-Aug-23 | Sale | 2,478 | $22.60 | $56,002.80 | (< 1%) 321.93K to 319.45K | |
| 16-Aug-23 6:20 PM View: | Denali Therapeutics Inc. (DNLI) | 14-Aug-23 | Sale (Planned) | 2,768 | $23.79 | $65,850.70 | (< 1%) 324.7K to 321.93K | |
| 14-Aug-23 5:12 PM View: | Denali Therapeutics Inc. (DNLI) | 10-Aug-23 | Sale | 2,857 | $24.15 | $68,996.50 | (< 1%) 327.56K to 324.7K | |
| 17-Feb-23 4:20 PM View: | Denali Therapeutics Inc. (DNLI) | 15-Feb-23 | Sale (Planned) | 1,476 | $29.40 | $43,394.40 | (< 1%) 329.03K to 327.56K | |
| 14-Feb-23 7:06 PM View: | Denali Therapeutics Inc. (DNLI) | 13-Feb-23 | Sale | 2,548 | $30.10 | $76,694.80 | (< 1%) 331.58K to 329.03K | |
| 14-Feb-23 7:06 PM View: | Denali Therapeutics Inc. (DNLI) | 10-Feb-23 | Sale (Planned) | 818 | $29.80 | $24,376.40 | (< 1%) 324.93K to 324.11K | |
| 10-Feb-23 6:12 PM View: | Denali Therapeutics Inc. (DNLI) | 08-Feb-23 | Sale | 1,521 | $30.88 | $46,968.50 | (< 1%) 333.92K to 332.4K | |
| 10-Jan-23 4:51 PM View: | Denali Therapeutics Inc. (DNLI) | 09-Jan-23 | Sale (Planned) | 1,459 | $28.48 | $41,552.30 | (< 1%) 335.38K to 333.92K | |
| 09-Jan-23 9:43 PM View: | Denali Therapeutics Inc. (DNLI) | 06-Jan-23 | Sale (Planned) | 1,451 | $28.67 | $41,600.20 | (< 1%) 336.83K to 335.38K | |
| 09-Jan-23 9:43 PM View: | Denali Therapeutics Inc. (DNLI) | 05-Jan-23 | Sale Duplicate | 2,636 | $28.44 | $74,967.80 | (< 1%) 339.47K to 336.83K | |
| 05-Jan-23 10:00 PM View: | Denali Therapeutics Inc. (DNLI) | 04-Jan-23 | Sale | 2,913 | $28.69 | $83,574.00 | (< 1%) 342.38K to 339.47K | |
| 05-Jan-23 10:00 PM View: | Denali Therapeutics Inc. (DNLI) | 03-Jan-23 | Grant | 41,120 | -- | -- | 14% 301.26K to 342.38K | |
| 25-Aug-22 6:10 PM View: | Denali Therapeutics Inc. (DNLI) | 23-Aug-22 | Sale (Planned) | 2,424 | $31.98 | $77,519.50 | (< 1%) 303.68K to 301.26K | |
| 23-Aug-22 4:45 PM View: | Denali Therapeutics Inc. (DNLI) | 19-Aug-22 | Sale | 2,576 | $33.22 | $85,574.70 | (< 1%) 306.26K to 303.68K | |
| 11-Aug-22 7:22 PM View: | Denali Therapeutics Inc. (DNLI) | 09-Aug-22 | Grant | 22,500 | -- | -- | 8% 283.76K to 306.26K | |
| 15-Feb-22 6:53 PM View: | Denali Therapeutics Inc. (DNLI) | 11-Feb-22 | Sale | 2,918 | $34.71 | $101,284.00 | (1%) 286.68K to 283.76K | |
| 11-Feb-22 5:16 PM View: | Denali Therapeutics Inc. (DNLI) | 09-Feb-22 | Market Sale | 1,423 | $37.10 | $52,791.50 | (< 1%) 288.1K to 286.68K | (9%) |
| 07-Jan-22 6:05 PM View: | Denali Therapeutics Inc. (DNLI) | 05-Jan-22 | Market Sale | 2,845 | $44.78 | $127,399.00 | (< 1%) 290.95K to 288.1K | 2% |
| 05-Jan-22 7:03 PM View: | Denali Therapeutics Inc. (DNLI) | 03-Jan-22 | Grant | 31,000 | -- | -- | 12% 259.95K to 290.95K | |
| 08-Dec-21 5:35 PM View: | Denali Therapeutics Inc. (DNLI) | 06-Dec-21 | Market Sale (Planned) | 1,476 | $42.52 | $62,759.50 | (< 1%) 261.42K to 259.95K | (4%) |
| 25-Aug-21 6:26 PM View: | Denali Therapeutics Inc. (DNLI) | 23-Aug-21 | Market Sale (Planned) | 6,143 | $48.91 | $300,454.00 | (2%) 267.56K to 261.42K | (7%) |
| 23-Aug-21 8:25 PM View: | Denali Therapeutics Inc. (DNLI) | 19-Aug-21 | Market Sale | 2,546 | $49.58 | $126,230.00 | (< 1%) 270.11K to 267.56K | 1% |
| 31-Mar-21 6:30 PM View: | Denali Therapeutics Inc. (DNLI) | 29-Mar-21 | Market Sale (Planned) | 2,822 | $54.62 | $154,126.00 | (1%) 272.52K to 269.7K | < 1% |
| 03-Mar-21 4:21 PM View: | Denali Therapeutics Inc. (DNLI) | 01-Mar-21 | Market Sale (Planned) | 7,092 | $66.38 | $470,741.00 | (3%) 279.62K to 272.52K | 5% |
| 16-Feb-21 7:43 PM View: | Denali Therapeutics Inc. (DNLI) | 11-Feb-21 | Market Sale | 3,156 | $70.33 | $221,972.00 | (1%) 282.77K to 279.62K | 4% |
| 11-Feb-21 7:10 PM View: | Denali Therapeutics Inc. (DNLI) | 09-Feb-21 | Market Option Sale | 1,470 | $74.68 | $109,785.00 | (< 1%) 195.87K to 194.4K | |
| 11-Feb-21 7:10 PM View: | Denali Therapeutics Inc. (DNLI) | 07-Feb-21 | Option Exercise Duplicate | 4,250 | -- | -- | 2% 191.62K to 195.87K | |
| 13-Oct-20 6:45 PM View: | Denali Therapeutics Inc. (DNLI) | 09-Oct-20 | Option Exercise | 30,000 | $5.28 | $158,400.00 | 16% 191.62K to 221.62K | |
| 13-Oct-20 6:45 PM View: | Denali Therapeutics Inc. (DNLI) | 09-Oct-20 | Market Option Sale (Planned) | 30,000 | $41.22 | $1,236,610.00 | (14%) 221.62K to 191.62K | |
| 13-Oct-20 6:45 PM View: | Denali Therapeutics Inc. (DNLI) | 08-Oct-20 | Option Exercise | 22,906 | $5.28 | $120,944.00 | 12% 191.62K to 214.52K | |
| 13-Oct-20 6:45 PM View: | Denali Therapeutics Inc. (DNLI) | 08-Oct-20 | Market Option Sale (Planned) | 22,906 | $40.12 | $918,989.00 | (11%) 214.52K to 191.62K | |
| 14-Sep-20 9:38 PM View: | Denali Therapeutics Inc. (DNLI) | 10-Sep-20 | Market Sale (Planned) | 3,689 | $31.00 | $114,359.00 | (2%) 193.83K to 190.14K | |
| 24-Aug-20 8:38 PM View: | Denali Therapeutics Inc. (DNLI) | 21-Aug-20 | Payment of Exercise | 1,954 | $32.88 | $64,247.50 | (1%) 160.27K to 158.32K | |
| 24-Aug-20 8:38 PM View: | Denali Therapeutics Inc. (DNLI) | 20-Aug-20 | Option Exercise | 5,643 | -- | -- | 4% 154.63K to 160.27K | |
| 01-Apr-20 6:18 PM View: | Denali Therapeutics Inc. (DNLI) | 30-Mar-20 | Market Sale | 1,428 | $19.48 | $27,817.40 | (< 1%) 156.06K to 154.63K | 2% |
| 23-Dec-19 7:35 PM View: | Denali Therapeutics Inc. (DNLI) | 23-Dec-19 | Market Sale (Planned) | 3,464 | $20.01 | $69,314.60 | (2%) 155.27K to 151.81K | (340%) |
| 23-Dec-19 7:35 PM View: | Denali Therapeutics Inc. (DNLI) | 20-Dec-19 | Market Sale (Planned) | 860 | $20.00 | $17,200.00 | (< 1%) 156.13K to 155.27K | 5% |
| 23-Dec-19 7:35 PM View: | Denali Therapeutics Inc. (DNLI) | 19-Dec-19 | Market Sale (Planned) | 2,566 | $20.00 | $51,320.00 | (2%) 158.7K to 156.13K | 5% |
| 22-Aug-19 7:49 PM View: | Denali Therapeutics Inc. (DNLI) | 21-Aug-19 | Payment of Exercise | 2,834 | $18.59 | $52,670.70 | (2%) 157.45K to 154.62K | |
| 22-Aug-19 7:49 PM View: | Denali Therapeutics Inc. (DNLI) | 20-Aug-19 | Option Exercise | 5,643 | -- | -- | 4% 151.81K to 157.45K | |
| 10-Jul-19 5:07 PM View: | Denali Therapeutics Inc. (DNLI) | 08-Jul-19 | Option Exercise | 6,511 | $5.28 | $34,378.10 | 4% 166.88K to 173.39K | |
| 10-Jul-19 5:07 PM View: | Denali Therapeutics Inc. (DNLI) | 08-Jul-19 | Market Option Sale (Planned) | 6,511 | $20.30 | $132,187.00 | (4%) 173.39K to 166.88K | |
| 10-Jul-19 5:07 PM View: | Denali Therapeutics Inc. (DNLI) | 08-Jul-19 | Market Sale (Planned) | 10,989 | $20.28 | $222,825.00 | (7%) 166.88K to 155.89K | |
| 12-Jun-19 6:13 PM View: | Denali Therapeutics Inc. (DNLI) | 10-Jun-19 | Option Exercise | 4,617 | $5.28 | $24,377.80 | 3% 175.68K to 180.3K |